OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
找到 12 篇相关文章
The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.
Anthropic's Claude Science is a workbench that gives scientists one environment to do computational research, saving them from the need to bounce between databases, pipelines, and tools.
Save up to $190 on your pass to TechCrunch Founder Summit 2026. Early Bird pricing ends today, at 11:59 p.m. PT, after which rates increase. Register now.
The new round values the physical AI startup that aims to automate heavy engineering and drug design at $41 billion.
Applications for Startup Battlefield 200 officially close on June 8, 11:59 p.m. PT. Don't wait any longer. Secure your shot at competing on the Disrupt Stage at TechCrunch Disrupt 2026 this October at San Francisco's Moscone West.
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.
CEO Ariel Katz argues that while AI can replicate workflow SaaS, it can't copy H1’s unique doctor data.
The Series B round was led by Battery Ventures.
Today is the final day to apply or nominate a startup for Startup Battlefield 200. Once the clock strikes 11:59 p.m. PT, the window closes on your chance to compete for $100,000 in equity-free funding, gain global visibility, connect directly with investors, and launch on the TechCrunch Disrupt stage.
There are only 3 days left to save up to $410 on your ticket to TechCrunch Disrupt 2026. Early Bird pricing ends May 29 at 11:59 p.m. PT, and once the deadline passes, ticket prices increase. If you plan to attend one of the most influential gatherings in tech this year, now is the time to lock in your pass before rates go up again.